Pacs Group, INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NYSE
Joshua Jergensen, President & COO of PACS Group, Inc., sold 40,000 shares of common stock on September 16, 2026.
NYSE
Mark Hancock, a Director and 10% owner of PACS Group, Inc., sold 300,000 shares of common stock on September 14, 2026.
NYSE
Jason Hulse Murray, Co-Founder, CEO & Chairman, a Director and 10% owner of PACS Group, Inc., sold 19,617 shares of common stock on September 10, 2026.
NYSE
Jason Hulse Murray, Co-Founder, CEO & Chairman, a Director and 10% owner of PACS Group, Inc., sold 51,887 shares of common stock on September 4, 2026.
NYSE
Jason Hulse Murray, Co-Founder, CEO & Chairman, a Director and 10% owner of PACS Group, Inc., sold 68,113 shares of common stock on September 1, 2026.
NYSE
Mark Hancock, a Director and 10% owner of PACS Group, Inc., reported a transaction in 88,000 shares of common stock on August 18, 2026.
NYSE
Patrick Hugh Conway, a Director of PACS Group, Inc., sold 3,497 shares of common stock on August 14, 2026 for $44.41 per share.
NYSE
Jason Hulse Murray, Co-Founder, CEO & Chairman, a Director and 10% owner of PACS Group, Inc., sold 150,550 shares of common stock on August 20, 2026.
NYSE
Jason Hulse Murray, Co-Founder, CEO & Chairman, a Director and 10% owner of PACS Group, Inc., sold 236,116 shares of common stock on August 17, 2026.
NYSE
Joshua Jergensen, President & COO of PACS Group, Inc., sold 40,000 shares of common stock on August 12, 2026.
NYSE
Joshua Jergensen, President & COO of PACS Group, Inc., sold 40,000 shares of common stock on July 15, 2026.
NYSE
Mark Hancock, a Director and 10% owner of PACS Group, Inc., sold 13,628 shares of common stock on July 14, 2026.
NYSE
Mark Hancock, a Director and 10% Owner of PACS Group, Inc., reported the sale of common stock totaling 25,304 shares through a pre-arranged Rule 10b5-1 trading plan.
NYSE
Michelle Renee Lewis, Chief Accounting Officer of PACS Group, Inc., has reported the sale of company stock totaling over 14,000 shares across three transactions executed between July 1st and July 6th, 2026, under a pre-established Rule 10b5-1 trading plan.
NYSE
PACS Group, Inc. Director Mark Hancock reported transactions involving the sale of common stock, executed under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Director Patrick Conway acquired 4,287 shares of PACS Group common stock through restricted stock units.
NYSE
Jacqueline Millard, a Director at PACS Group, Inc., acquired 4,287 shares of common stock through restricted stock units.
NYSE
Director Taylor Leavitt acquired 4,287 shares of PACS Group common stock through restricted stock units.
NYSE
Evelyn Dilsaver, a Director at PACS Group, Inc., reported the acquisition of 4,287 shares of common stock on July 1, 2026, as part of a restricted stock unit grant.
NYSE
PACS Group, Inc. Director Mark Hancock reported the sale of common stock totaling over 200,000 shares through a pre-arranged 10b5-1 trading plan.
NYSE
Michelle Renee Lewis, Chief Accounting Officer of PACS Group, Inc., reported a sale of 15,000 shares of common stock executed on June 25, 2026, under a pre-arranged Rule 10b5-1 trading plan.
NYSE
PACS Group, Inc. Director Mark Hancock has sold a significant number of shares through a pre-arranged trading plan, indicating a planned divestment strategy.
NYSE
Director Patrick Hugh Conway was granted 4,660 restricted stock units in PACS Group, Inc. as part of standard equity compensation.
NYSE
Director Taylor S. Leavitt was granted 4,660 restricted stock units as part of his compensation package with PACS Group, Inc.
NYSE
Director Jacqueline Millard was granted 4,660 restricted stock units in PACS Group, Inc. as part of a standard equity award.
NYSE
Director Evelyn Dilsaver was granted 4,660 restricted stock units in PACS Group, Inc. as part of an equity compensation arrangement.
NYSE
Chief Legal Officer John Todd Mitchell sold 80,152 shares of PACS Group common stock via a pre-arranged 10b5-1 trading plan.
NYSE
PACS Group CFO Carey Hendrickson was granted 48,426 restricted stock units vesting over three years.
NYSE
Chief Accounting Officer Michelle Renee Lewis reported the withholding of 24,691 shares of PACS Group common stock to satisfy tax obligations.
NYSE
Chief Legal Officer John Todd Mitchell reported the withholding of 66,471 shares to satisfy tax obligations upon the vesting of restricted stock units.